Adalimumab for interleukin-1beta-mediated chronic non-scarring scalp folliculitis: Case report and literature review. Soglia S, Maione V, Bugatti M, Vermi W, et al. J Dermatol 2022;49:157-160.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Soglia S, Maione V, Bugatti M, Vermi W, et al. Adalimumab for interleukin-1beta-mediated chronic non-scarring scalp folliculitis: Case report and literature review. J Dermatol 2022;49:157-160.
PMID: 34472127